Germany: Engineering Wood Bags Multi-Million Dollar Contract to Build Biotech Facility for Teva

Editor: Ahlam Rais

Once completed, the biotech plant is expected to produce pharmaceutical ingredients from cell cultures.

Related Vendors

Wood will provide engineering, procurement, construction management, commissioning and qualification for Teva’s new biotechnological facility in Germany.
Wood will provide engineering, procurement, construction management, commissioning and qualification for Teva’s new biotechnological facility in Germany.
(Source: Deposit Photos)

Georgia/USA – Wood has been awarded a multi-million dollar contract by Teva Biotech to provide engineering, procurement, construction management, commissioning and qualification for a new biotechnological facility to be built in Ulm, Germany.

The plant will produce pharmaceutical ingredients from cell cultures in a new eight-storey building to be constructed within Teva’s existing biotechnology production site. Wood EAAA Capital Projects Group will execute detailed design and procurements services for a lump sum fee, as well as construction management and commissioning/qualification services under a reimbursable contract. Expected completion will be 2020, while tech transfer is planned to begin in 2021.

Prior to this award, Wood completed basic design and an investment cost estimate for the same facility under a previous contract, which was awarded on a competitive basis.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:45334692)